Alpha Tau Medical Shares Clinical Trial Data Update
Ticker: DRTSW · Form: 6-K · Filed: Jan 27, 2025 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | Jan 27, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: clinical-trials, press-release, medical-technology
TL;DR
Alpha Tau Medical is sharing interim clinical trial data soon, watch for updates.
AI Summary
On January 27, 2025, Alpha Tau Medical Ltd. announced that cornerstone interim data from multiple clinical trials will be presented at their R&D Update Day. This information was shared via a press release attached to a Form 6-K filing.
Why It Matters
This filing indicates Alpha Tau Medical is progressing in its clinical trials, potentially leading to future product development and market entry for its medical technologies.
Risk Assessment
Risk Level: medium — Clinical trial data updates are important but do not guarantee regulatory approval or commercial success.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- January 27, 2025 (date) — Date of press release and filing
FAQ
What is the main purpose of this Form 6-K filing?
The Form 6-K filing is to report a press release issued by Alpha Tau Medical Ltd. on January 27, 2025, announcing that cornerstone interim data from multiple clinical trials will be shared at their R&D Update Day.
What is the title of the press release attached to this filing?
The title of the press release is "Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day."
When was the press release issued?
The press release was issued on January 27, 2025.
What type of company is Alpha Tau Medical Ltd.?
Alpha Tau Medical Ltd. is a company in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry, with SIC code 3841.
Where is Alpha Tau Medical Ltd. headquartered?
Alpha Tau Medical Ltd. is headquartered in Jerusalem, Israel.
Filing Stats: 306 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2025-01-27 09:02:02
Filing Documents
- ea0228780-6k_alphatau.htm (6-K) — 13KB
- ea022878001ex99-1_alphatau.htm (EX-99.1) — 48KB
- 0001213900-25-006757.txt ( ) — 63KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alpha Tau Medical Ltd. Date: January 27, 2025 By: /s/ Uzi Sofer Uzi Sofer Chief Executive Officer 3